These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26611984)

  • 21. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Policy statement--recommendations for the prevention and treatment of influenza in children, 2009 -2010.
    Committee on Infectious Diseases
    Pediatrics; 2009 Oct; 124(4):1216-26. PubMed ID: 19736264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy.
    Moro PL; Tepper NK; Grohskopf LA; Vellozzi C; Broder K
    Expert Rev Vaccines; 2012 Aug; 11(8):911-21. PubMed ID: 23002972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Variability in the reporting of adverse reactions to the pandemic and seasonal influenza vaccine: seasons 2009-2010 and 2010-2011. Valencian community, Spain].
    Alguacil Ramos AM; Lluch Rodrigo JA; Portero Alonso A; Martín Ivorra R; Pastor Villalba E
    Rev Esp Salud Publica; 2012; 86(3):241-51. PubMed ID: 22991081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active surveillance of adverse events following immunization against pandemic influenza A (H1N1) in Korea.
    Choe YJ; Cho H; Song KM; Kim JH; Han OP; Kwon YH; Bae GR; Lee HJ; Lee JK
    Jpn J Infect Dis; 2011; 64(4):297-303. PubMed ID: 21788704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Japan's immunisation policy in routine, pandemic and post-tsunami situations.
    Murashige N
    Int J Clin Pract; 2011 Nov; 65(11):1126-31. PubMed ID: 21995691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza and immunization: a quantitative study of media coverage in the season of the «Fluad case».
    Odone A; Chiesa V; Ciorba V; Cella P; Pasquarella C; Signorelli C
    Epidemiol Prev; 2015; 39(4 Suppl 1):139-45. PubMed ID: 26499432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safety.
    Haber P; Iskander J; Walton K; Campbell SR; Kohl KS
    Pediatrics; 2011 May; 127 Suppl 1():S39-44. PubMed ID: 21502243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccines against influenza A (H1N1) pandemic.
    Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
    Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010.
    Yih WK; Lee GM; Lieu TA; Ball R; Kulldorff M; Rett M; Wahl PM; McMahill-Walraven CN; Platt R; Salmon DA
    Am J Epidemiol; 2012 Jun; 175(11):1120-8. PubMed ID: 22582207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine hesitancy: Causes, consequences, and a call to action.
    Salmon DA; Dudley MZ; Glanz JM; Omer SB
    Vaccine; 2015 Nov; 33 Suppl 4():D66-71. PubMed ID: 26615171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to win trust over flu.
    Nature; 2009 Oct; 461(7265):698. PubMed ID: 19812628
    [No Abstract]   [Full Text] [Related]  

  • 33. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.
    Vellozzi C; Broder KR; Haber P; Guh A; Nguyen M; Cano M; Lewis P; McNeil MM; Bryant M; Singleton J; Martin D; DeStefano F
    Vaccine; 2010 Oct; 28(45):7248-55. PubMed ID: 20850534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance.
    Kurz X; Domergue F; Slattery J; Segec A; Szmigiel A; Hidalgo-Simon A
    Vaccine; 2011 Jun; 29(26):4378-87. PubMed ID: 21501644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The new H1N1 and HPV vaccines and old fears.
    Balofsky A; Agmon-Levin N; Shoenfeld Y
    Curr Opin Rheumatol; 2010 Jul; 22(4):431-6. PubMed ID: 20485175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine hesitancy and unfalsifiability.
    Glick M
    J Am Dent Assoc; 2015 Jul; 146(7):491-3. PubMed ID: 26113088
    [No Abstract]   [Full Text] [Related]  

  • 37. Pandemics and health equity: lessons learned from the H1N1 response in Los Angeles County.
    Plough A; Bristow B; Fielding J; Caldwell S; Khan S
    J Public Health Manag Pract; 2011; 17(1):20-7. PubMed ID: 21135657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010.
    Parrella A; Gold M; Marshall H; Braunack-Mayer A; Watson M; Baghurst P
    Hum Vaccin Immunother; 2012 May; 8(5):662-7. PubMed ID: 22634441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recommendations for prevention and control of influenza in children, 2012-2013.
    Committee on Infectious Diseases, American Academy of Pediatrics
    Pediatrics; 2012 Oct; 130(4):780-92. PubMed ID: 22966032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007.
    Fiore AE; Shay DK; Haber P; Iskander JK; Uyeki TM; Mootrey G; Bresee JS; Cox NJ;
    MMWR Recomm Rep; 2007 Jul; 56(RR-6):1-54. PubMed ID: 17625497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.